Despite overwhelming evidence that vaping devices are far less harmful than combustible cigarettes, JUUL's meteoric path to capturing nearly 70 percent of the U.S. e-cigarette market has sparked mixed feelings among the public and scientific communities.
Proponents of e-cigs' health benefits worry that the company's roaring success among underage high-schoolers may outweigh the scores of existing smokers who are quitting in favor of a healthier life through JUUL. Meanwhile, a coalition of nicotine prohibitionists has labeled JUUL as a “public health disaster”—a campaign running counter to all evidence, as exposed by John Tierney in City Journal's latest summer edition.
